DXN (ASX: DXN) has attained its highest-ever contracted backlog of $40.9 million in early FY27, supported by recent AI high-performance computing (HPC) contract wins and a growing pipeline of modular data centre projects across Australia and Asia-Pacific.

🏗️ Record backlog: DXN’s backlog has increased from $23.5 million as at 30 June 2026 to $40.9 million as at 30 August 2026, following further contract wins across AI infrastructure, aviation and transport.
🤖 AI demand accelerates: DXN’s maiden AI HPC contract, worth approximately $8.8 million, was signed in June 2026 for a 1.36MW modular AI HPC data centre.
🌏 Scaling for growth: While DXN’s FY26 revenue figure of $10.1 million was down 33% on the prior year number on the back of customer-side project deferrals, activity levels increased materially in the second half.

“Our near-term priority is the successful delivery and commissioning of the AI HPC pilot, the key catalyst for converting our indicative US$200 million-plus follow-on opportunity into contracted work.” – Shalini Lagrutta, DXN Managing Director

Why is NEXTDC (ASX:NXT) spending almost $6 billion to build things it`s already sold? NEXTDC sells data centre capacity by the megawatt and it`s signed binding contracts for 740 but it`s only built 288, and billing customers for 175. While the customers have committed, the capacity doesn`t exist yet.

To help pay for all that, NEXTDC has raised almost $10 billion since August and plans to spend up to $5.75 billion this current financial year. That gap is the entire business model. You don`t build a data centre and hope someone rents it. You sign the customer first, then build.

Which works right up until it doesn`t - Build on time, and the order book becomes years of contracted revenue. Miss, and it`s a very expensive promise.

#AI #tech #money #stock #AI

Myopharm Limited is developing treatments for metabolic and inflammatory diseases, led by its Type 2 diabetes candidate TriGlytza®. A recent preclinical study achieved its key HbA1c endpoint and delivered stronger results than metformin over one month of treatment. With FDA and Australian ethics approvals supporting the Resilience Phase 2a programme, alongside new research into Type 1 diabetes, CEO & Executive Chair Karinza Phoenix joins The Stock Network’s Lel Smits to discuss TriGlytza®, the company’s clinical pathway and recent milestones.

💊 Advancing TriGlytza® for Type 2 diabetes
🧬 Progressing the Resilience Phase 2a programme
🔬 Exploring opportunities in Type 1 diabetes

Does China need Nvidia’s chips to build AI? A model called Ox-Alpha recently appeared on a platform developers use to test AI. It had no company name and offered unlimited free access yet within days, it became the most used model on the site.

A Chinese AI lab called Z.ai has come forward and claimed it - the interesting part is that Z.ai said the entire high-traffic week was run exclusively on domestic Chinese AI chips not Nvidia hardware, and after software optimization, the cost per token was competitive with mainstream Nvidia GPUs.

Nvidia just told investors to expect nothing from China next quarter because the Chinese government is restricting what its companies can buy. It looks like Chinese AI is doing just fine without them anyway.

#AI #Nvidia #China #Tech #Money

Change Financial (ASX:CCA) has delivered a landmark FY26 result, achieving its maiden full-year profit while beating upgraded revenue and EBITDA guidance. Revenue grew 21%, underlying EBITDA surged 17 times and the company’s Vertexon PaaS platform has become the largest contributor to group revenue as it continues to scale across Australia and New Zealand. CEO Tony Sheehan joins The Stock Network’s @LelSmits to discuss the milestone result, the growth of Vertexon and the next phase of expansion.

💰 Reaching maiden profitability
📈 Scaling the Vertexon PaaS platform
📊 Accelerating growth into FY27

Axiant Resources has listed on the ASX with the ticker code of AXR. The company was formed to hold the gold and base metal exploration assets being demerged from ASX-listed mining group Core Lithium (ASX:CXO). Subject to the completion of this planned demerger, Axiant Resources will hold a portfolio of seven projects. Its flagship Shoobridge Gold Project, along with the Adelaide River, Finniss, Albarta and Jervois Projects span the highly prospective Pine Creek region located in the Northern Territory. The remaining two projects are located in South Australia. Core Lithium is expected to retain a significant shareholding in Axiant Resources following completion of its IPO raising.

Board of Directors: Independent Non-Executive Chairman - Greg English; Managing Director and Chief Executive Officer - Michael Fechner; Independent Non‑Executive Director - Peter Bewick

Senior Management: Chief Financial Officer & Company Secretary - Daniel Travers

Media: The Stock Network, Lel Smits

Imagion Biosystems (ASX:IBX) is advancing a new approach to cancer detection with MagSense®, its non-radioactive, bio-safe molecular MRI imaging agent designed to help clinicians detect cancer earlier and with greater precision. With key Contract Research Organisation (CRO) work orders signed, investigational product manufacturing complete and discussions with seven prospective U.S. clinical trial sites in process, Imagion Biosystems Chair Bob Proulx joins The Stock Network`s Lel Smits to discuss how the company is moving through the critical steps required to launch the study.

🧪 Preparing for the start of the Phase 2 trial
🏥 Getting sites ready for patients
🚀 Imagion Biosystems’ near-term expectations

DUG Technology (ASX:DUG) has secured a US$9.3 million, two-year contract with a national oil company to provide hosted high-performance computing (HPC) infrastructure and access to its DUG Insight software platform.

💻 US$9.3m contract: The two-year agreement commences in the first quarter of DUG Technology’s 2027 financial year, with the company providing hosted HPC infrastructure to support the client’s advanced subsurface processing and imaging requirements. The counterparty has not been named for commercially sensitive reasons.

🛢️ Geoscience computing demand: The contract gives the client access to DUG Technology’s full DUG Insight processing and imaging toolkit, enabling advanced workflows for processing and interpreting subsurface data. The award highlights demand for specialised computing infrastructure and software within the energy sector.

⚡ Integrated technology platform: The company’s HPC infrastructure and DUG Insight platform combines cloud-based HPC facilities, proprietary software, immersion cooling technology and geoscience services. The company says its technology is designed to help clients maximise the value of seismic data and support more informed decision-making.